Inadvertent Extended use of ImplanonR Contraceptive Implants by Clients in Jos, Nigeria: An Interesting Finding
- PMID: 38803702
- PMCID: PMC11128159
- DOI: 10.60787/NMJ-63-2-90
Inadvertent Extended use of ImplanonR Contraceptive Implants by Clients in Jos, Nigeria: An Interesting Finding
Abstract
Background: Contraceptive implants are popular methods among women accessing family planning in Jos. Women appear to be using these methods for longer periods despite adequate counselling including the use for a maximum period prescribed by the manufacturers.
Methodology: This was a retrospective, cross sectional study of all clients who had ImplanonR classic removed between May 2006 and December 2019. The register of acceptors of the implant was retrieved and relevant variables collated and analyzed for age, duration of use of the implant and the indication for removal. The data was analyzed using the Stata statistical software version 14, College Station, Texas, USA.
Results: A total of 1,805 implants were inserted, when all of them would have been removed, only 596(33%) were documented to have been removed. The mean age of the clients was 31.031 ± 5.56 years, range 18-51 years. The mean duration of use of ImplanonR was 29.370 ± 11.756 months, range 0.5-72months. About 83(13.9%) implants were used beyond the expected duration of use of 36 months. By the 3rd, 4th, and 5th years, 86.1%, 97.5% and 99.2% had had the implants removed. Clients used the method beyond the stipulated expiration of the implants, up to twice the period expected. There was no failure or pregnancy recorded.
Conclusion: About one-sixth of women extended the use of ImplanonR implants. This may be more as only 33.0% of them returned for removal at the facility where it was inserted. However, there was no pregnancy recorded in this group of women despite the extended duration of use.
Keywords: Contraceptive Implants; Extended Use; ImplanonR Classic; Jos; Nigeria.
Copyright © 2022 Nigerian Medical Association.
Similar articles
-
Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.East Afr Med J. 2010 Nov;87(11):461-4. East Afr Med J. 2010. PMID: 23457809
-
Indications for removal of intrauterine contraceptive devices in Jos, north-central Nigeria.Niger J Clin Pract. 2006 Dec;9(2):105-8. Niger J Clin Pract. 2006. PMID: 17319339
-
"I have come to remove it because of heavy bleeding": a mixed-methods study on early contraceptive implant removal and the underlying factors in eastern Uganda.Contracept Reprod Med. 2024 Apr 16;9(1):17. doi: 10.1186/s40834-024-00279-7. Contracept Reprod Med. 2024. PMID: 38627845 Free PMC article.
-
Task Shifting Provision of Contraceptive Implants to Community Health Extension Workers: Results of Operations Research in Northern Nigeria.Glob Health Sci Pract. 2015 Sep 15;3(3):382-94. doi: 10.9745/GHSP-D-15-00129. Print 2015 Sep. Glob Health Sci Pract. 2015. PMID: 26374800 Free PMC article. Review.
-
Subdermal contraceptive implants.J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):223-6. doi: 10.1016/0960-0760(95)00051-z. J Steroid Biochem Mol Biol. 1995. PMID: 7626459 Review.
References
-
- Mutihir JT. Daru PH. Implanon sub-dermal implants: a 10-month review of acceptablity in Jos, North-Central Nigeria. Nig J Clin Practice. 2008; 11: 330-323. - PubMed
-
- Wenzl R, van Beek A, Schnabel P, Huber J. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception 1998; 58:283–288. - PubMed
-
- Kiriwat O, Patanayindee A, Koetsawang S, Korver T, Bennink HJ. A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand. Eur J Contracept Reprod Health Care 1998; 3:85–91. - PubMed
LinkOut - more resources
Full Text Sources